Stock search

Ticker or company name

Compare stocks

Market: US

  • HCAHCA Healthcare
  • CVSCVS Health
  • SYKStryker Corporation

Add stock

Ticker or company

Summary

HCA
HCA Healthcare
$511,78Up +2,55%
Year: Up +5%
69/100Ratio would watch
Open stock page
CVS
CVS Health
$88,59Down −0,85%
Year: Up +13%
83/100Best scoreRatio would consider buying
Open stock page
SYK
Stryker Corporation
$310,72Up +0,35%
Year: Down −17%
72/100Ratio would consider buying
Open stock page

Verdict

CVS has the best score (83). SYK grows revenue the fastest. CVS is the cheapest by forward P/E. CVS has the lowest debt load. SYK has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckHCA4 ✓ 3 — 1 ✕CVS6 ✓ 3 — 0 ✕SYK5 ✓ 3 — 1 ✕
P/E vs its history15,410,433,0
P/E vs industry15,410,433,0
Forward P/E15,210,718,2
Revenue growth, YoY+5,8%+6,7%+7,9%
EPS growth, YoY+16,5%+2 107,7%+23,4%
Net margin8,6%2,6%13,8%
Net debt / EBITDAn/a—−0,81,8
Free cash flow$5,97 bn$15,6 bn$4,57 bn
Share count over a year−8,0%+1,7%−0,5%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterHCATTMCVSTTMSYKTTMIndustry medianTTM
P/E TTM ↓15,4Best: 10,4Worst: 33,025,1
Forward P/E ↓15,2Best: 10,7Worst: 18,216,2
PEG ↓1,8Best: 1,8Worst: 3,12,2
P/S TTM ↓1,3Best: 0,3Worst: 4,52,2
EV/EBITDA ↓Best: 9,710,8Worst: 21,517,3
P/FCF ↓17,5Best: 7,3Worst: 26,119,5

Price, %

  • HCAn/a
  • CVSn/a
  • SYKn/a

Returns

Best WorstNo mark — in between

PeriodHCACVSSYK
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

HCACVSSYK
Share of “buy”Worst: 58%Best: 88%77%
Beat the forecast3 of 4Best: 4 of 4Worst: 2 of 4
Average “surprise”+4,1%Best: +22,0%Worst: −2,5%
Insiders over 12 monthssales $47,5 msales $322 msales $580 m

Details are on each stock page.